Literature DB >> 30747363

A 29-year-old woman with persistent thrombocytopenia.

Irene Di Pasquale1, Antonella Bertomoro2, Fabrizio Vianello3, Piero Marson4, Francesca Boscaro2, Fabrizio Fabris2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30747363     DOI： 10.1007/s11739-019-02030-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  14 in total

1.  AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.

Authors:  Virginia C Broudy; Nancy L Lin
Journal:  Cytokine       Date:  2004-01-21       Impact factor: 3.861

2.  Long-term outcomes in adults with chronic ITP after splenectomy failure.

Authors:  Robert McMillan; Carol Durette
Journal:  Blood       Date:  2004-04-20       Impact factor: 22.113

Review 3.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

4.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

5.  Refractory idiopathic thrombocytopenic purpura treated with immunoadsorption using tryptophan column.

Authors:  Erdal Kurtoğlu; Volkan Karakuş; Burak Deveci
Journal:  Transfus Apher Sci       Date:  2013-04-28       Impact factor: 1.764

Review 6.  State of the art - how I manage immune thrombocytopenia.

Authors:  Nichola Cooper
Journal:  Br J Haematol       Date:  2017-03-10       Impact factor: 6.998

7.  Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).

Authors:  Donna M Boruchov; Sri Gururangan; M Catherine Driscoll; James B Bussel
Journal:  Blood       Date:  2007-08-13       Impact factor: 22.113

8.  Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.

Authors:  James B Bussel; Gregory Cheng; Mansoor N Saleh; Bethan Psaila; Lidia Kovaleva; Balkis Meddeb; Janusz Kloczko; Habib Hassani; Bhabita Mayer; Nicole L Stone; Michael Arning; Drew Provan; Julian M Jenkins
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

9.  [Refractory idiopathic thrombocytopenic purpura which responded to protein A column].

Authors:  T Tauchi; A Suzuki; T Fujimura; H Iwabuchi; J H Ohyashiki; K Ohyashiki; K Toyama; H Nagasawa
Journal:  Rinsho Ketsueki       Date:  1989-08

10.  Mycophenolate mofetil therapy for severe immune thrombocytopenia.

Authors:  Alice Taylor; Lucy Neave; Shalini Solanki; John Paul Westwood; Ilaria Terrinonive; Siobhan McGuckin; Jaimal Kothari; Nichola Cooper; Roberto Stasi; Marie Scully
Journal:  Br J Haematol       Date:  2015-08-06       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.